Your browser doesn't support javascript.
loading
An update on the regulatory mechanisms of NLRP3 inflammasome activation.
Paik, Seungwha; Kim, Jin Kyung; Silwal, Prashanta; Sasakawa, Chihiro; Jo, Eun-Kyeong.
Afiliación
  • Paik S; Department of Microbiology, Chungnam National University School of Medicine, Daejeon, Korea.
  • Kim JK; Infection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, Korea.
  • Silwal P; Department of Microbiology, Chungnam National University School of Medicine, Daejeon, Korea.
  • Sasakawa C; Infection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, Korea.
  • Jo EK; Department of Microbiology, Chungnam National University School of Medicine, Daejeon, Korea.
Cell Mol Immunol ; 18(5): 1141-1160, 2021 05.
Article en En | MEDLINE | ID: mdl-33850310
The NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome is a multiprotein complex involved in the release of mature interleukin-1ß and triggering of pyroptosis, which is of paramount importance in a variety of physiological and pathological conditions. Over the past decade, considerable advances have been made in elucidating the molecular mechanisms underlying the priming/licensing (Signal 1) and assembly (Signal 2) involved in NLRP3 inflammasome activation. Recently, a number of studies have indicated that the priming/licensing step is regulated by complicated mechanisms at both the transcriptional and posttranslational levels. In this review, we discuss the current understanding of the mechanistic details of NLRP3 inflammasome activation with a particular emphasis on protein-protein interactions, posttranslational modifications, and spatiotemporal regulation of the NLRP3 inflammasome machinery. We also present a detailed summary of multiple positive and/or negative regulatory pathways providing upstream signals that culminate in NLRP3 inflammasome complex assembly. A better understanding of the molecular mechanisms underlying NLRP3 inflammasome activation will provide opportunities for the development of methods for the prevention and treatment of NLRP3 inflammasome-related diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inflamasomas / Proteína con Dominio Pirina 3 de la Familia NLR Límite: Animals / Humans Idioma: En Revista: Cell Mol Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inflamasomas / Proteína con Dominio Pirina 3 de la Familia NLR Límite: Animals / Humans Idioma: En Revista: Cell Mol Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article
...